188 results on '"Hiwasa, Takaki"'
Search Results
2. Association of high proprotein convertase subtilisin/kexin type 9 antibody level with poor prognosis in patients with diabetes: a prospective study
3. Analysis of patients with colorectal cancer shows a specific increase in serum anti-ING1 autoantibody levels
4. Low anti-CFL1 antibody with high anti-ACTB antibody is a poor prognostic factor in esophageal squamous cell carcinoma
5. Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers
6. Combination of high anti‐SKI and low anti‐TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma.
7. JMJD6 Autoantibodies as a Potential Biomarker for Atherosclerosis-Related Diseases
8. Stage-Specific Alteration and Prognostic Relationship of Serum Fumarate Hydratase Autoantibodies in Gastric Cancer.
9. Autoantibody in Cancer
10. Elevated levels of autoantibodies against DNAJC2 in sera of patients with atherosclerotic diseases
11. Combinational antibody detection approach increases the clinical validity of colorectal cancer screening
12. Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke
13. Serum anti-SERPINE1 antibody as a potential biomarker of acute cerebral infarction
14. Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction
15. Serum anti-AP3D1 antibodies are risk factors for acute ischemic stroke related with atherosclerosis
16. GADD34 activates p53 and may have utility as a marker of atherosclerosis
17. Nardilysin is a promising biomarker for the early diagnosis of acute coronary syndrome
18. Utility of atherosclerosis-associated serum antibodies against colony-stimulating factor 2 in predicting the onset of acute ischemic stroke and prognosis of colorectal cancer
19. Prognostic and diagnostic significance of preoperative Jumonji domain‑containing 6 antibodies in colorectal cancer
20. The combination of positive anti‑WDR1 antibodies with negative anti‑CFL1 antibodies in serum is a poor prognostic factor for patients with esophageal carcinoma
21. Serum anti-PCK1 antibody levels are prognostic factor for the patients with diabetes mellitus
22. Association of high proprotein convertase subtilisin/kexin type 9 antibody level with poor prognosis in patients with diabetes: A prospective cross-sectional study
23. High proprotein convertase subtilisin/kexin type 9 antibody level is associated with poor prognosis in patients with diabetes: A Prospective cross-sectional study
24. Novel serum autoantibodies against talin1 in multiple sclerosis: Possible pathogenetic roles of the antibodies
25. Identification of antibody against wingless‑type MMTV integration site family member 7B as a biliary cancer tumor marker
26. Serum anti‑TSTD2 antibody as a biomarker for atherosclerosis‑induced ischemic stroke and chronic kidney disease
27. GADD34 activates p53 and may have utility as a marker of atherosclerosis
28. 1221-P: Clinical Significance of Autoantibody Measurement for Glucose-Dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 in the Plasma
29. Serum Anti-BRAT1 is a Common Molecular Biomarker for Gastrointestinal Cancers and Atherosclerosis
30. The Pluripotent Stem-Cell Marker Alkaline Phosphatase is Highly Expressed in Refractory Glioblastoma with DNA Hypomethylation
31. Serum WT1‑271 IgM antibody as a novel diagnostic marker for Gastric Cancer
32. MPC-8 Serum anti-zinc finger FYVE domain-containing protein 21 (ZFYVE21) autoantibody as a novel biomarker for oligodendroglioma IDH-mutant and 1p/19q co-deletion
33. Presence of serum RalA and serum p53 autoantibodies in 1833 patients with various types of cancers
34. Identification of serum anti‑striatin 4 antibodies as a common marker for esophageal cancer and other solid cancers
35. Association of Serum Anti-PCSK9 Antibody Levels with Favorable Postoperative Prognosis in Esophageal Cancer
36. Prevalence of serum galectin‑1 autoantibodies in seven types of cancer: A potential biomarker
37. Additional file 1 of Serum anti-DIDO1, anti-CPSF2, and anti-FOXJ2 antibodies as predictive risk markers for acute ischemic stroke
38. Novel serum autoantibodies against ß-actin (ACTB) in amyotrophic lateral sclerosis
39. Multipanel assay of 17 tumor‐associated antibodies for serological detection of stage 0/I breast cancer
40. Anti-KIAA0513 Antibody as a Broad-spectrum Biomarker of Mortal Atherosclerotic and Cancerous Diseases
41. Serum Anti-AP3D1 Antibodies Are Risk Factors for Acute Ischemic Stroke Related With Atherosclerosis
42. Anti‐FIRΔexon2 autoantibody as a novel indicator for better overall survival in gastric cancer
43. Serum Anti-AP3D1 Antibodies Are Broad-Spectrum Biomarkers for Atherosclerosis, Acute Ischemic Stroke, Cardiovascular Disease, Diabetes Mellitus, Chronic Kidney Disease, and Digestive Organ Cancer
44. Serum anti‐LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases
45. Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction
46. Association between serum anti‑ASXL2 antibody levels and acute ischemic stroke, acute myocardial infarction, diabetes mellitus, chronic kidney disease and digestive organ cancer, and their possible association with atherosclerosis and hypertension
47. Association of serum levels of antibodies against ALDOA and FH4 with transient ischemic attack and cerebral infarction
48. Circulating Anti-Sorting Nexins 16 Antibodies as an Emerging Biomarker of Coronary Artery Disease in Patients with Obstructive Sleep Apnea
49. The accuracy of flow cytometric cell-based assay to detect anti-myelin oligodendrocyte glycoprotein (MOG) antibodies determining the optimal method for positivity judgement
50. Cross Correlation Statistical Study of Biomarker for Cerebral Infarction
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.